Jamjoom Pharmaceuticals Factory Company (4015.SR)
SAR 157.4
(-0.51%)
SAR 157.4
(-0.51%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 313.37 Million SAR | 34.32% |
| 2022 | 233.32 Million SAR | 24.94% |
| 2021 | 186.75 Million SAR | -24.74% |
| 2020 | 248.13 Million SAR | 42.17% |
| 2019 | 174.53 Million SAR | 1.55% |
| 2018 | 171.86 Million SAR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 95.67 Million SAR | -8.24% |
| 2024 Q1 | 126.58 Million SAR | 199.96% |
| 2024 Q2 | 104.25 Million SAR | -17.64% |
| 2023 Q4 | 42.2 Million SAR | -50.16% |
| 2023 FY | 313.4 Million SAR | 34.32% |
| 2023 Q3 | 84.67 Million SAR | -8.52% |
| 2023 Q2 | 92.55 Million SAR | -1.44% |
| 2023 Q1 | 93.9 Million SAR | 145.44% |
| 2022 Q2 | 57.61 Million SAR | -25.58% |
| 2022 Q1 | 77.42 Million SAR | 27.61% |
| 2022 FY | 233.32 Million SAR | 24.94% |
| 2022 Q4 | 38.26 Million SAR | -36.26% |
| 2022 Q3 | 60.03 Million SAR | 4.2% |
| 2021 FY | 186.75 Million SAR | -24.74% |
| 2021 Q4 | 60.66 Million SAR | 0.0% |
| 2021 Q3 | 60.66 Million SAR | 22.01% |
| 2021 Q2 | 49.72 Million SAR | 54.27% |
| 2021 Q1 | 32.23 Million SAR | 0.0% |
| 2020 FY | 248.13 Million SAR | 42.17% |
| 2019 FY | 174.53 Million SAR | 1.55% |
| 2018 FY | 171.86 Million SAR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Saudi Pharmaceutical Industries and Medical Appliances Corporation | 89.39 Million SAR | -250.544% |